serogroup b
<p>Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By <em>Neisseria meningitidis</em> Serogroup B</p>
20
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak
9
Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine
14
Combined Administration of Meningococcal Serogroup B Outer Membrane Vesicle Vaccine and Conjugated Serogroup C Vaccine Indicated for Prevention of Meningococcal Disease Is Safe and Immunogenic
7
Development of a DNA Aptamer for Screening Neisseria meningitidis Serogroup B by Cell SELEX
9
Meningococcal Serogroup B Vaccine Immunogenicity in High-Risk Groups: What Are the Implications?
5
Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010
7
Characterization of murine monoclonal antibodies against serogroup B salmonellae and application as serotyping reagents
5
Standardization of Neisseria meningitidis Serogroup B Colorimetric Serum Bactericida Assay
6
Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease.
9
Molecular Epidemiology of Recent Belgian Isolates of Neisseria meningitidis Serogroup B
7
Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex.
8
Distinct evolutionary patterns of Neisseria meningitidis serogroup B disease outbreaks at two universities in the USA
10
Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatisinfections
7
Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines
8
Invasive Meningococcal Disease in Québec, Canada, Due to an Emerging Clone of ST 269 Serogroup B Meningococci with Serotype Antigen 17 and Serosubtype Antigen P1 19 (B:17:P1 19)
7
Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older
9
Understanding the Category B Recommendation for Serogroup B Meningococcal Vaccine
5
Invasive Serogroup B Neisseria meningitidis in Québec, Canada, 2003 to 2010: Persistence of the ST 269 Clone Since It First Emerged in 2003
7
Adoption of Serogroup B Meningococcal Vaccine Recommendations
12